Controversies accumulated around betablockers
Betablockers are one of the most successful drug classes in cardiology. They have many indications - starting with treatment of arterial hypertension, continuing with secondary prevention post myocardial infarction up to the treatment of heart failure with reduced ejection fraction. Recently, many analysis and information were published which are questioning yet unshakable role of betablockers in some cardiovascular diagnosis. This review article summarizes the controversies, which have accumulated around betablockers in the treatment of hypertension, secondary prevention of coronary artery disease, perioperative administration in patients undegoing non-cardiac surgery and treatment of heart failure with reduced ejection fraction. Some of these controversies already led to guidelines modifications, other will probably lead to guidelines changes in near future.Key words: arterial hypertension - betablockers - heart failure - perioperative care - secondary prevention..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2015 |
|---|---|
| Erschienen: |
2015 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:61 |
|---|---|
| Enthalten in: |
Vnitřnı lékařství - 61(2015), 5, Seite 410 |
| Sprache: |
Tschechisch |
|---|
| Beteiligte Personen: |
Hradec, Jaromír [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Adrenergic beta-Antagonists - therapeutic use |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
OLC1962135233 |
|---|
| LEADER | 01000caa a2200265 4500 | ||
|---|---|---|---|
| 001 | OLC1962135233 | ||
| 003 | DE-627 | ||
| 005 | 20230508123451.0 | ||
| 007 | tu | ||
| 008 | 160206s2015 xx ||||| 00| ||cze c | ||
| 028 | 5 | 2 | |a PQ20160617 |
| 035 | |a (DE-627)OLC1962135233 | ||
| 035 | |a (DE-599)GBVOLC1962135233 | ||
| 035 | |a (PRQ)pubmed_primary_260758490 | ||
| 035 | |a (KEY)N0524285420150000061000500410controversiesaccumulatedaroundbetablockers | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a cze | ||
| 082 | 0 | 4 | |a 610 |q DNB |
| 100 | 1 | |a Hradec, Jaromír |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Controversies accumulated around betablockers |
| 264 | 1 | |c 2015 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 520 | |a Betablockers are one of the most successful drug classes in cardiology. They have many indications - starting with treatment of arterial hypertension, continuing with secondary prevention post myocardial infarction up to the treatment of heart failure with reduced ejection fraction. Recently, many analysis and information were published which are questioning yet unshakable role of betablockers in some cardiovascular diagnosis. This review article summarizes the controversies, which have accumulated around betablockers in the treatment of hypertension, secondary prevention of coronary artery disease, perioperative administration in patients undegoing non-cardiac surgery and treatment of heart failure with reduced ejection fraction. Some of these controversies already led to guidelines modifications, other will probably lead to guidelines changes in near future.Key words: arterial hypertension - betablockers - heart failure - perioperative care - secondary prevention. | ||
| 650 | 4 | |a Hypertension - drug therapy | |
| 650 | 4 | |a Heart Failure - prevention & control | |
| 650 | 4 | |a Adrenergic beta-Antagonists - therapeutic use | |
| 650 | 4 | |a Hypertension - complications | |
| 650 | 4 | |a Secondary Prevention - methods | |
| 650 | 4 | |a Heart Failure - etiology | |
| 773 | 0 | 8 | |i Enthalten in |t Vnitřnı lékařství |d Praha : Česká Lékařská Společnost Jana Evangelisty Purkyně, 1955 |g 61(2015), 5, Seite 410 |w (DE-627)166267376 |w (DE-600)138213-5 |w (DE-576)014611228 |x 0042-773X |7 nnns |
| 773 | 1 | 8 | |g volume:61 |g year:2015 |g number:5 |g pages:410 |
| 856 | 4 | 2 | |u http://www.ncbi.nlm.nih.gov/pubmed/26075849 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a GBV_ILN_4219 | ||
| 951 | |a AR | ||
| 952 | |d 61 |j 2015 |e 5 |h 410 | ||